• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超选择眼动脉内化疗在非人类灵长类动物模型中的组织病理学发现。

Superselective intraophthalmic artery chemotherapy in a nonhuman primate model: histopathologic findings.

机构信息

Department of Ophthalmology, Hamilton Eye Institute, University of Tennessee Health Science Center, Memphis, TN 38103, USA.

出版信息

JAMA Ophthalmol. 2013 Jul;131(7):903-11. doi: 10.1001/jamaophthalmol.2013.2065.

DOI:10.1001/jamaophthalmol.2013.2065
PMID:23619956
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4251809/
Abstract

IMPORTANCE

We describe the histopathologic findings in a nonhuman primate (NHP) model of superselective intraophthalmic artery chemotherapy (SSIOAC), detailing ocular and orbital vascular adverse effects.

OBJECTIVE

To further document, using comprehensive ocular and orbital histopathology, previously reported toxic effects observed with real-time ophthalmoscopy during SSIOAC in a NHP model.

DESIGN

Comparative interventional case series.

SETTING

Preclinical trial approved under the guidelines of the Institutional Animal Care and Utilization committee.

PARTICIPANTS

Six adult male rhesus macaques (Macacca mulatta).

INTERVENTIONS

The right eye of each NHP was treated with 3 cycles of SSIOAC using either melphalan (5 mg/30 mL) or carboplatin (30 mg/30 mL). Both eyes in each animal were enucleated 6 hours after the final procedure, before euthanasia and formalin perfusion of the NHP; we then performed orbital dissection of the arterial vasculature and optic nerves.

MAIN OUTCOME MEASURES

Histopathologic examination of the eyes, optic nerves, and orbital vessels of the 6 treated NHPs.

RESULTS

We found leukostasis with retinal arteriole occlusion in all treated eyes. Retinal endothelial cells stained positive for 2 inflammatory markers, intercellular adhesion molecule 1 and interleukin 8. Transmission electron microscopy revealed occlusion of the retinal vessels with ultrastructural changes in the endothelial cells and surrounding pericytes. Additional findings included nerve fiber layer infarcts, central retinal artery thrombosis, hypertrophy and occlusion of choroidal arteries with disruption of the internal elastic lamina, patchy choroidal inflammation, and birefringent intravascular foreign bodies. Orbital findings included ophthalmic artery and central retinal artery wall dissection, fracturing of the internal elastic lamina, intimal hyperplasia, and eyelid vessel damage. Optic nerves displayed hemorrhage, leukostasis, and foreign body crystallization. Control eyes, optic nerves, and orbital vessels were normal.

CONCLUSIONS AND RELEVANCE

Histopathologic examination of our nonhuman primate model for SSIOAC revealed significant toxic effects in the ocular and orbital vasculature. These findings substantiate previous observations with real-time retinal imaging and parallel reported vascular toxic effects in children with retinoblastoma treated with SSIOAC.

摘要

重要性

我们描述了一种非人类灵长类动物(NHP)模型中超选择性眼内动脉化疗(SSIOAC)的组织病理学发现,详细描述了眼部和眼眶血管的不良反应。

目的

使用全面的眼部和眼眶组织病理学,进一步记录在 NHP 模型中 SSIOAC 实时眼底镜检查中观察到的先前报道的毒性作用。

设计

比较干预性病例系列。

设置

在机构动物护理和利用委员会的指导下批准的临床前试验。

参与者

六只成年雄性恒河猴(Macacca mulatta)。

干预措施

每只 NHP 的右眼接受 3 个周期的 SSIOAC 治疗,使用美法仑(5mg/30ml)或卡铂(30mg/30ml)。在最后一次手术 6 小时后,每只动物的双眼在安乐死和正式灌注 NHP 之前被摘除,然后对动脉血管和视神经进行眼眶解剖。

主要观察指标

6 只治疗 NHP 的眼部、视神经和眼眶血管的组织病理学检查。

结果

我们发现所有治疗眼均有白细胞淤滞伴视网膜小动脉闭塞。视网膜内皮细胞对 2 种炎症标志物细胞间黏附分子 1 和白细胞介素 8 呈阳性染色。透射电子显微镜显示视网膜血管闭塞,内皮细胞和周围周细胞的超微结构发生变化。其他发现包括神经纤维层梗死、视网膜中央动脉血栓形成、脉络膜动脉肥大和闭塞伴有内弹性层破裂、斑片状脉络膜炎症和双折射血管内异物。眼眶发现包括眼动脉和视网膜中央动脉壁夹层、内弹性层断裂、内膜增生和眼睑血管损伤。视神经显示出血、白细胞淤滞和异物结晶。对照眼、视神经和眼眶血管正常。

结论和相关性

我们对 SSIOAC 的非人类灵长类动物模型进行的组织病理学检查显示,眼部和眼眶血管存在显著的毒性作用。这些发现证实了以前用实时视网膜成像观察到的结果,并与接受 SSIOAC 治疗的视网膜母细胞瘤患儿的平行报告的血管毒性作用相一致。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abcb/4251809/aea7b152c076/nihms516073f10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abcb/4251809/afe5e59e064b/nihms516073f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abcb/4251809/99db2aa573c1/nihms516073f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abcb/4251809/51fbffd2e55b/nihms516073f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abcb/4251809/7bf43f934273/nihms516073f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abcb/4251809/7585467c695c/nihms516073f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abcb/4251809/4ddf6fa37f68/nihms516073f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abcb/4251809/94be658ca485/nihms516073f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abcb/4251809/ceae3dde9c7c/nihms516073f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abcb/4251809/169f3e2b8483/nihms516073f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abcb/4251809/aea7b152c076/nihms516073f10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abcb/4251809/afe5e59e064b/nihms516073f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abcb/4251809/99db2aa573c1/nihms516073f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abcb/4251809/51fbffd2e55b/nihms516073f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abcb/4251809/7bf43f934273/nihms516073f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abcb/4251809/7585467c695c/nihms516073f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abcb/4251809/4ddf6fa37f68/nihms516073f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abcb/4251809/94be658ca485/nihms516073f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abcb/4251809/ceae3dde9c7c/nihms516073f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abcb/4251809/169f3e2b8483/nihms516073f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abcb/4251809/aea7b152c076/nihms516073f10.jpg

相似文献

1
Superselective intraophthalmic artery chemotherapy in a nonhuman primate model: histopathologic findings.超选择眼动脉内化疗在非人类灵长类动物模型中的组织病理学发现。
JAMA Ophthalmol. 2013 Jul;131(7):903-11. doi: 10.1001/jamaophthalmol.2013.2065.
2
Real-time ophthalmoscopic findings of superselective intraophthalmic artery chemotherapy in a nonhuman primate model.非人灵长类动物模型中超选择性眼内动脉化疗的实时检眼镜检查结果
Arch Ophthalmol. 2011 Nov;129(11):1458-65. doi: 10.1001/archophthalmol.2011.330.
3
Intra-ophthalmic artery chemotherapy triggers vascular toxicity through endothelial cell inflammation and leukostasis.眼内动脉化疗通过血管内皮细胞炎症和白细胞淤滞引发血管毒性。
Invest Ophthalmol Vis Sci. 2012 Apr 30;53(4):2439-45. doi: 10.1167/iovs.12-9466.
4
Histopathologic observations after intra-arterial chemotherapy for retinoblastoma.视网膜母细胞瘤动脉内化疗后的组织病理学观察
Arch Ophthalmol. 2011 Nov;129(11):1416-21. doi: 10.1001/archophthalmol.2011.223. Epub 2011 Jul 11.
5
Rabbit Model of Intra-Arterial Chemotherapy Toxicity Demonstrates Retinopathy and Vasculopathy Related to Drug and Dose, Not Procedure or Approach.兔动脉内化疗毒性模型显示与药物和剂量相关的视网膜病变和血管病变,与操作过程或方法无关。
Invest Ophthalmol Vis Sci. 2019 Mar 1;60(4):954-964. doi: 10.1167/iovs.18-25346.
6
Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery).超选择性眼动脉化疗作为视网膜母细胞瘤(化疗手术)的主要治疗方法。
Ophthalmology. 2010 Aug;117(8):1623-9. doi: 10.1016/j.ophtha.2009.12.030. Epub 2010 Apr 9.
7
Validating a nonhuman primate model of super-selective intraophthalmic artery chemotherapy: comparing ophthalmic artery diameters.验证超选择性眼内动脉化疗的非人灵长类动物模型:比较眼动脉直径。
Invest Ophthalmol Vis Sci. 2012 Nov 27;53(12):7791-4. doi: 10.1167/iovs.12-10605.
8
A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results.一项关于美法仑经动脉(眼动脉)直接化疗用于眼内视网膜母细胞瘤的I/II期研究:初步结果
Ophthalmology. 2008 Aug;115(8):1398-404, 1404.e1. doi: 10.1016/j.ophtha.2007.12.014. Epub 2008 Mar 14.
9
OPHTHALMIC VASCULAR EVENTS AFTER INTRA-ARTERIAL CHEMOTHERAPY FOR RETINOBLASTOMA: Real-World Comparison Between Primary and Secondary Treatments.眼内血管事件在视网膜母细胞瘤的动脉内化疗后:原发性与继发性治疗的真实世界比较。
Retina. 2019 Dec;39(12):2264-2272. doi: 10.1097/IAE.0000000000002315.
10
Pharmacokinetics, Tissue Localization, Toxicity, and Treatment Efficacy in the First Small Animal (Rabbit) Model of Intra-Arterial Chemotherapy for Retinoblastoma.眼内动脉化疗治疗视网膜母细胞瘤的首例小动物(兔)模型的药代动力学、组织定位、毒性和疗效。
Invest Ophthalmol Vis Sci. 2018 Jan 1;59(1):446-454. doi: 10.1167/iovs.17-22302.

引用本文的文献

1
Advances in treatment of adenoid cystic carcinoma of the lacrimal gland.泪腺腺样囊性癌的治疗进展
Int J Ophthalmol. 2025 Aug 18;18(8):1570-1578. doi: 10.18240/ijo.2025.08.20. eCollection 2025.
2
Treatment strategies and prognostic insights for lacrimal gland adenoid cystic carcinoma: a review.泪腺腺样囊性癌的治疗策略与预后见解:综述
Discov Oncol. 2025 May 22;16(1):858. doi: 10.1007/s12672-025-02468-5.
3
Advancements in Nanosystems for Ocular Drug Delivery: A Focus on Pediatric Retinoblastoma.纳米系统在眼部药物输送中的进展:以小儿视网膜母细胞瘤为重点。

本文引用的文献

1
Validating a nonhuman primate model of super-selective intraophthalmic artery chemotherapy: comparing ophthalmic artery diameters.验证超选择性眼内动脉化疗的非人灵长类动物模型:比较眼动脉直径。
Invest Ophthalmol Vis Sci. 2012 Nov 27;53(12):7791-4. doi: 10.1167/iovs.12-10605.
2
Real-time ophthalmoscopic findings of intraophthalmic artery chemotherapy in retinoblastoma.视网膜母细胞瘤眼内动脉化疗的实时检眼镜检查结果
Arch Ophthalmol. 2012 Aug;130(8):1075-7. doi: 10.1001/archophthalmol.2012.180.
3
Intra-ophthalmic artery chemotherapy triggers vascular toxicity through endothelial cell inflammation and leukostasis.
Molecules. 2024 May 11;29(10):2263. doi: 10.3390/molecules29102263.
4
MR Imaging of Adverse Effects and Ocular Growth Decline after Selective Intra-Arterial Chemotherapy for Retinoblastoma.视网膜母细胞瘤选择性动脉内化疗后不良反应及眼生长发育减退的磁共振成像
Cancers (Basel). 2024 May 16;16(10):1899. doi: 10.3390/cancers16101899.
5
Retinal Optical Coherence Tomography Angiography Findings following Retinoblastoma Treatment by Chemotherapy.视网膜母细胞瘤化疗治疗后的视网膜光学相干断层扫描血管造影结果
J Curr Ophthalmol. 2023 Apr 29;34(4):452-459. doi: 10.4103/joco.joco_323_21. eCollection 2022 Oct-Dec.
6
Retinal microvasculature observations of fellow eyes after intra-arterial chemotherapy for unilateral retinoblastoma using optical coherence tomography angiography.使用光学相干断层扫描血管造影术对单侧视网膜母细胞瘤进行动脉内化疗后对侧眼视网膜微血管的观察。
Front Med (Lausanne). 2023 Jan 10;9:1015301. doi: 10.3389/fmed.2022.1015301. eCollection 2022.
7
Efficacy of second-course intra-arterial chemotherapy in children for advanced retinoblastoma recurrence after intra-arterial chemotherapy.二次动脉内化疗对儿童晚期视网膜母细胞瘤动脉内化疗后复发的疗效
J Interv Med. 2019 Apr 30;1(2):98-101. doi: 10.19779/j.cnki.2096-3602.2018.02.07. eCollection 2018 May.
8
Intravitreal HDAC Inhibitor Belinostat Effectively Eradicates Vitreous Seeds Without Retinal Toxicity In Vivo in a Rabbit Retinoblastoma Model.玻璃体内注射组蛋白去乙酰化酶抑制剂贝利司他可有效根除兔视网膜母细胞瘤模型体内的玻璃体细胞,且无视网膜毒性。
Invest Ophthalmol Vis Sci. 2021 Nov 1;62(14):8. doi: 10.1167/iovs.62.14.8.
9
Efficacy, Toxicity, and Pharmacokinetics of Intra-Arterial Chemotherapy Versus Intravenous Chemotherapy for Retinoblastoma in Animal Models and Patients.在动物模型和患者中,眼内动脉化疗与静脉化疗治疗视网膜母细胞瘤的疗效、毒性和药代动力学比较。
Transl Vis Sci Technol. 2021 Sep 1;10(11):10. doi: 10.1167/tvst.10.11.10.
10
Evaluation of intravitreal topotecan dose levels, toxicity and efficacy for retinoblastoma vitreous seeds: a preclinical and clinical study.眼内注射拓扑替康剂量水平、毒性和疗效评估用于治疗视网膜母细胞瘤玻璃体内种子:一项临床前和临床研究。
Br J Ophthalmol. 2022 Feb;106(2):288-296. doi: 10.1136/bjophthalmol-2020-318529. Epub 2021 May 10.
眼内动脉化疗通过血管内皮细胞炎症和白细胞淤滞引发血管毒性。
Invest Ophthalmol Vis Sci. 2012 Apr 30;53(4):2439-45. doi: 10.1167/iovs.12-9466.
4
Superselective ophthalmic artery infusion of melphalan for intraocular retinoblastoma: preliminary results from 140 treatments.超选择性眼动脉灌注氨甲蝶呤治疗眼内视网膜母细胞瘤:140 例治疗的初步结果。
Acta Ophthalmol. 2013 Jun;91(4):335-42. doi: 10.1111/j.1755-3768.2011.02296.x. Epub 2012 Jan 23.
5
Efficacy and complications of super-selective intra-ophthalmic artery melphalan for the treatment of refractory retinoblastoma.超选择性眼内动脉丝裂霉素治疗难治性视网膜母细胞瘤的疗效及并发症。
Ophthalmology. 2012 Mar;119(3):611-6. doi: 10.1016/j.ophtha.2011.08.045. Epub 2011 Dec 22.
6
Enucleated eyes after failed intra-arterial infusion of chemotherapy for unilateral retinoblastoma: histopathologic evaluation of vitreous seeding.经动脉内化疗治疗单侧视网膜母细胞瘤失败后的眼球摘除:玻璃体种植的组织病理学评估
Clin Ophthalmol. 2011;5:1655-8. doi: 10.2147/OPTH.S24318. Epub 2011 Nov 24.
7
Real-time ophthalmoscopic findings of superselective intraophthalmic artery chemotherapy in a nonhuman primate model.非人灵长类动物模型中超选择性眼内动脉化疗的实时检眼镜检查结果
Arch Ophthalmol. 2011 Nov;129(11):1458-65. doi: 10.1001/archophthalmol.2011.330.
8
Histopathologic observations after intra-arterial chemotherapy for retinoblastoma.视网膜母细胞瘤动脉内化疗后的组织病理学观察
Arch Ophthalmol. 2011 Nov;129(11):1416-21. doi: 10.1001/archophthalmol.2011.223. Epub 2011 Jul 11.
9
Intra-arterial chemotherapy for retinoblastoma: report No. 1, control of retinal tumors, subretinal seeds, and vitreous seeds.视网膜母细胞瘤的动脉内化疗:第1号报告,视网膜肿瘤、视网膜下播散灶及玻璃体内播散灶的控制
Arch Ophthalmol. 2011 Nov;129(11):1399-406. doi: 10.1001/archophthalmol.2011.150. Epub 2011 Jun 13.
10
Intra-arterial chemotherapy for retinoblastoma: report No. 2, treatment complications.视网膜母细胞瘤的动脉内化疗:第2号报告,治疗并发症
Arch Ophthalmol. 2011 Nov;129(11):1407-15. doi: 10.1001/archophthalmol.2011.151. Epub 2011 Jun 13.